Chukwuebuka Egbuna
Also known as: Egbuna, C., C. Egbuna, Egbuna, Chukwuebuka
Research areas: Agricultural and Biological Sciences · Plant Science · Medicinal Plant Research · Phytochemicals and Antioxidant Activities · Bioactive natural compounds
0000-0001-8382-0693
About
Chukwuebuka Egbuna is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. Egbuna has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited over 25 books with Elsevier, Springer, Wiley and Taylor & Francis. His most recent book is a 3 volume set book on Coronavirus Drug Discovery. Egbuna is also the founder and the publishing director of IPS Intelligentsia Publishing Services. He is a reviewer and editorial board member of various journals. His primary research interests cut across biochemistry (nutrition and toxicology), phytochemistry, food and medicinal chemistry.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (115)
- Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review Save
- Wnt/β‐catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside‐1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study Save
- Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review Save
- Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review Save
- Inhibition of oxidative stress and advanced glycation end‐product formation in purified BSA /glucose glycation system by polyphenol extracts of selected nuts from Pakistan Save
- Inhibition of oxidative stress and advanced glycation end‐product formation in purified BSA /glucose glycation system by polyphenol extracts of selected nuts from Pakistan Save
- FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies Save
- Molecular Docking of Phytocompounds of Lamiaceae Family Targeting the Oncogene Protein [PDB ID: 5p21] Save
- Molecular Docking of Phytocompounds of Lamiaceae Family Targeting the Oncogene Protein [PDB ID: 5p21] Save
- Global Research Funding and Development Save
- Ficus exasperata Attenuates Acetaminophen‐Induced Hepatic Damage via NF‐κB Signaling Mechanism in Experimental Rat Model Save
- Banana Peel as a Source of Nutraceuticals Save
- Chapter 15 - Coronavirus disease 2019 in Africa: why the recent spike in cases? Save
- Coronavirus disease 2019 in Africa: why the recent spike in cases? Save
- Dexamethasone Save
- Drug discovery opportunities from traditional practices against SARS-CoV-2 Save
- Marine organisms as a potential source of antiviral drugs for the treatment of coronavirus infections and other viral diseases Save
- Myth surrounding the FDA disapproval of hydroxychloroquine sulfate and chloroquine phosphate as drugs for coronavirus disease 2019 Save
- Nutritional management against severe acute respiratory syndrome coronavirus-2 infection Save
- Orange Peel as Source of Nutraceuticals Save